Hamlin Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $218M | Sell |
791,153
-303
| -0% | -$83.5K | 5.05% | 2 |
|
2025
Q1 | $210M | Buy |
791,456
+10,909
| +1% | +$2.89M | 5.03% | 2 |
|
2024
Q4 | $181M | Buy |
780,547
+35,857
| +5% | +$8.33M | 4.49% | 8 |
|
2024
Q3 | $164M | Buy |
744,690
+103,959
| +16% | +$22.9M | 4.12% | 12 |
|
2024
Q2 | $126M | Sell |
640,731
-454
| -0.1% | -$89.3K | 3.71% | 15 |
|
2024
Q1 | $138M | Buy |
641,185
+830
| +0.1% | +$179K | 4.08% | 12 |
|
2023
Q4 | $135M | Sell |
640,355
-7,499
| -1% | -$1.58M | 4.24% | 7 |
|
2023
Q3 | $130M | Buy |
647,854
+2,221
| +0.3% | +$445K | 4.46% | 8 |
|
2023
Q2 | $120M | Buy |
645,633
+1,763
| +0.3% | +$327K | 4.01% | 14 |
|
2023
Q1 | $123M | Sell |
643,870
-7,516
| -1% | -$1.44M | 4.3% | 9 |
|
2022
Q4 | $110M | Buy |
651,386
+89,511
| +16% | +$15.1M | 3.89% | 14 |
|
2022
Q3 | $99.5M | Buy |
561,875
+31,274
| +6% | +$5.54M | 3.98% | 12 |
|
2022
Q2 | $109M | Buy |
530,601
+58,047
| +12% | +$11.9M | 4.35% | 10 |
|
2022
Q1 | $112M | Sell |
472,554
-2,334
| -0.5% | -$555K | 3.96% | 13 |
|
2021
Q4 | $108M | Sell |
474,888
-248
| -0.1% | -$56.7K | 3.85% | 12 |
|
2021
Q3 | $91.9M | Buy |
475,136
+4,827
| +1% | +$933K | 3.66% | 14 |
|
2021
Q2 | $100M | Buy |
470,309
+47,854
| +11% | +$10.2M | 3.94% | 10 |
|
2021
Q1 | $86.3M | Buy |
422,455
+46,430
| +12% | +$9.48M | 3.54% | 19 |
|
2020
Q4 | $68.5M | Buy |
+376,025
| New | +$68.5M | 3.16% | 21 |
|